Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 4

Results: 10

Cover Image, Volume 43, Issue 4.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. i, doi. 10.1002/cac2.12424

By:

Suzuki, Hiroyuki;
Iwamoto, Hideki;
Seki, Takahiro;
Nakamura, Toru;
Masuda, Atsutaka;
Sakaue, Takahiko;
Tanaka, Toshimitsu;
Imamura, Yasuko;
Niizeki, Takashi;
Nakano, Masahito;
Shimose, Shigeo;
Shirono, Tomotake;
Noda, Yu;
Kamachi, Naoki;
Sakai, Miwa;
Morita, Kazutoyo;
Nakayama, Masamichi;
Yoshizumi, Tomoharu;
Kuromatsu, Ryoko;
Yano, Hirohisa

Publication type:

Article

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 455, doi. 10.1002/cac2.12414

By:

Eun, Jung Woo;
Yoon, Jung Hwan;
Ahn, Hye Ri;
Kim, Seokhwi;
Kim, Young Bae;
Lim, Su Bin;
Park, Won;
Kang, Tae Wook;
Baek, Geum Ok;
Yoon, Moon Gyeong;
Son, Ju A;
Weon, Ji Hyang;
Kim, Soon Sun;
Cho, Hyo Jung;
Cheong, Jae Youn

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2023, v. 43, n. 4, p. 413, doi. 10.1002/cac2.12301
Publication type:: Article

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 480, doi. 10.1002/cac2.12413

By:

Miao, Daojia;
Wang, Qi;
Shi, Jian;
Lv, Qingyang;
Tan, Diaoyi;
Zhao, Chuanyi;
Xiong, Zhiyong;
Zhang, Xiaoping

Publication type:

Article

Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 415, doi. 10.1002/cac2.12411

By:

Suzuki, Hiroyuki;
Iwamoto, Hideki;
Seki, Takahiro;
Nakamura, Toru;
Masuda, Atsutaka;
Sakaue, Takahiko;
Tanaka, Toshimitsu;
Imamura, Yasuko;
Niizeki, Takashi;
Nakano, Masahito;
Shimose, Shigeo;
Shirono, Tomotake;
Noda, Yu;
Kamachi, Naoki;
Sakai, Miwa;
Morita, Kazutoyo;
Nakayama, Masamichi;
Yoshizumi, Tomoharu;
Kuromatsu, Ryoko;
Yano, Hirohisa

Publication type:

Article

Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 435, doi. 10.1002/cac2.12412

By:

Liu, Chaofan;
Wang, Xi;
Qin, Wan;
Tu, Jingyao;
Li, Chunya;
Zhao, Weiheng;
Ma, Li;
Liu, Bo;
Qiu, Hong;
Yuan, Xianglin

Publication type:

Article

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 519, doi. 10.1002/cac2.12406

By:

Iwasa, Satoru;
Wang, Zi‐Xian;
Muro, Kei;
Morita, Satoshi;
Park, Young Suk;
Zhang, Dongsheng;
Yamada, Yasuhide;
Sakamoto, Junichi;
Kim, Tae Won

Publication type:

Article

Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 513, doi. 10.1002/cac2.12405

By:

Hao, Yang;
Ma, Sen;
Gu, Zili;
Haghparast, Alireza;
Schomann, Timo;
Yu, Zhenfeng;
He, Yuanyuan;
Dong, Xiaoxv;
Cruz, Luis J;
ten Dijke, Peter

Publication type:

Article

Impact of small molecule‐mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 508, doi. 10.1002/cac2.12402

By:

Makris, Georgios;
Kayhan, Semih;
Kreuzer, Marvin;
Rüfenacht, Véronique;
Faccin, Erica;
Underhaug, Jarl;
Diez‐Fernandez, Carmen;
Knobel, Philip A.;
Poms, Martin;
Gougeard, Nadine;
Rubio, Vicente;
Martinez, Aurora;
Pruschy, Martin;
Häberle, Johannes

Publication type:

Article

A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer.

Published in:

Cancer Communications, 2023, v. 43, n. 4, p. 503, doi. 10.1002/cac2.12401

By:

Shaurova, Tatiana;
Yan, Lingyue;
Su, Yafei;
Rich, Laurie James;
Vincent‐Chong, Vui King;
Calkins, Hannah;
Pokharel, Saraswati;
Petkovich, Martin;
Seshadri, Mukund;
Wu, Yun;
Hershberger, Pamela Anne

Publication type:

Article